[Antimicrobial effect of carbenicillin combined with prodigiosin and lysozyme in chronic purulent-inflammatory diseases complicated by Proteus infection].
D002228:Carbenicillin / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009113:Muramidase / Q000008:administration & dosage* / Q000627:therapeutic use; D011353:Prodigiosin / Q000008:administration & dosage* / Q000627:therapeutic use; D011512:Proteus Infections / Q000188:drug therapy*; D012883:Skin Ulcer / Q000188:drug therapy*
D009113:Muramidase; D002228:Carbenicillin; D011353:Prodigiosin
Antimikrobnoe deĭstvie karbenitsillina v sochetanii s prodigiozanom i lizotsimom pri khronicheskikh gnoĭno-vospalitel'nykh zabolevaniiakh, oslozhnennykh Proteem